HER-2 amplification and topoisomerase II alpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報

  • CRID
    1570854175416485760
  • NII論文ID
    10018769092
  • データソース種別
    • CiNii Articles

問題の指摘

ページトップへ